Donald Goff
Donald Goff
NYU School of Medicine
Verified email at nyumc.org
Title
Cited by
Cited by
Year
Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia …
JP McEvoy, JM Meyer, DC Goff, HA Nasrallah, SM Davis, L Sullivan, ...
Schizophrenia research 80 (1), 19-32, 2005
13832005
The emerging role of glutamate in the pathophysiology and treatment of schizophrenia
DC Goff, JT Coyle
American Journal of Psychiatry 158 (9), 1367-1377, 2001
10752001
Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five-year naturalistic study
DC Henderson, E Cagliero, C Gray, RA Nasrallah, DL Hayden, ...
American Journal of Psychiatry 157 (6), 975-981, 2000
10162000
Regionally localized thinning of the cerebral cortex in schizophrenia
GR Kuperberg, MR Broome, PK McGuire, AS David, M Eddy, F Ozawa, ...
Archives of general psychiatry 60 (9), 878-888, 2003
9712003
Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects.
DC Goff, DC Henderson, E Amico
The American journal of psychiatry, 1992
7601992
Impaired recruitment of the hippocampus during conscious recollection in schizophrenia
S Heckers, S Rauch, D Goff, C Savage, D Schacter, A Fischman, N Alpert
Nature neuroscience 1 (4), 318-323, 1998
6601998
Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline
HA Nasrallah, JM Meyer, DC Goff, JP McEvoy, SM Davis, TS Stroup, ...
Schizophrenia research 86 (1-3), 15-22, 2006
6362006
A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls
DC Goff, LM Sullivan, JP McEvoy, JM Meyer, HA Nasrallah, GL Daumit, ...
Schizophrenia research 80 (1), 45-53, 2005
5902005
Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance
DS Manoach, RL Gollub, ES Benson, MM Searl, DC Goff, E Halpern, ...
Biological psychiatry 48 (2), 99-109, 2000
5722000
Cognitive therapy for psychosis in schizophrenia: an effect size analysis
RA Gould, KT Mueser, E Bolton, V Mays, D Goff
Focus 48 (1), 335-101, 2004
5252004
A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia
RW Buchanan, M Davis, D Goff, MF Green, RSE Keefe, AC Leon, ...
Schizophrenia bulletin 31 (1), 5-19, 2005
5102005
A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia
DC Goff, G Tsai, J Levitt, E Amico, D Manoach, DA Schoenfeld, ...
Archives of general psychiatry 56 (1), 21-27, 1999
4831999
Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia
JT COYLE, G TSAI, D GOFF
Annals of the New York Academy of Sciences 1003 (1), 318-327, 2003
4522003
Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI
DS Manoach, DZ Press, V Thangaraj, MM Searl, DC Goff, E Halpern, ...
Biological psychiatry 45 (9), 1128-1137, 1999
4501999
Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis
DC Henderson, E Cagliero, PM Copeland, CP Borba, AE Evins, ...
Archives of general psychiatry 62 (1), 19-28, 2005
4482005
Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists.
DC Goff, C Cather, AE Evins, DC Henderson, O Freudenreich, ...
The Journal of clinical psychiatry, 2005
4112005
Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1
JM Meyer, VG Davis, DC Goff, JP McEvoy, HA Nasrallah, SM Davis, ...
Schizophrenia research 101 (1-3), 273-286, 2008
3452008
Reduced sleep spindles and spindle coherence in schizophrenia: mechanisms of impaired memory consolidation?
EJ Wamsley, MA Tucker, AK Shinn, KE Ono, SK McKinley, AV Ely, ...
Biological psychiatry 71 (2), 154-161, 2012
3162012
Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations
O Freudenreich, DC Goff
Acta Psychiatrica Scandinavica 106 (5), 323-330, 2002
3112002
Dose-finding trial for D-cycloserine added to neuroleptics for negative symptoms in schizophrenia.
DC Goff, G Tsai, DS Manoach, JT Coyle
The American journal of psychiatry, 1995
3021995
The system can't perform the operation now. Try again later.
Articles 1–20